Hepatitis B Virus Reactivation under Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia

被引：6
|
作者：
Iskender, Gulsen [1 ]
Iskender, Dicle [2 ]
Ertek, Mustafa [1 ]
机构：
[1] Dr Abdurrahman Yurtaslan Ankara Oncol Training &, Clin Infect Dis & Clin Microbiol, Ankara, Turkey
[2] Dr Abdurrahman Yurtaslan Ankara Oncol Training &, Clin Hematol & Blood & Marrow Transplantat, Ankara, Turkey
来源：
TURKISH JOURNAL OF HEMATOLOGY | 2020年 / 37卷 / 03期
关键词：
Hepatitis B reactivation; Ibrutinib; Chronic lymphocytic leukemia;
D O I：
10.4274/tjh.galenos.2020.2019.0180
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：208 / 209
页数：3
相关论文
共 50 条
  • [1] Hepatitis B Virus Reactivation in a Chronic Lymphocytic Leukemia Patient Treated with Ibrutinib
    Choi, Jung Hye
    Hur, Joon Young
    Won, Young-Woong
    [J]. CANCER RESEARCH AND TREATMENT, 2023, 55 (02): : 704 - 705
  • [2] Hepatitis B Virus Reactivation with Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review
    Yildirim, Arzu Altuncekic
    Kurt, Celali
    Ulkuden, Burcu
    Cetinkol, Yeliz
    [J]. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2024, 30 (01): : 19 - 22
  • [3] Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation
    Yang, Shenmiao
    Zhu, Rong
    Li, Nan
    Feng, Yu
    Zuo, Rui
    Gale, Robert Peter
    Huang, Xiaojun
    [J]. ACTA HAEMATOLOGICA, 2022, 145 (01) : 54 - 62
  • [4] Fludarabine and risk of hepatitis B virus reactivation in chronic lymphocytic leukemia
    Yagci, M
    Sucak, GT
    Haznedar, R
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2000, 64 (03) : 233 - 234
  • [5] Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia
    Tjonnfjord, Sara Kristina Viberg
    Tjonnfjord, Eirik Brekka
    Konopski, Zbigniew
    Tjonnfjord, Geir Erland
    [J]. CASE REPORTS IN HEMATOLOGY, 2021, 2021
  • [6] Hepatitis B virus reactivation after ibrutinib treatment
    Alventosa Mateu, Carlos
    Urquijo Ponce, Juan Jose
    Mena Duran, Armando
    Latorre Sanchez, Mercedes
    Castello Miralles, Inmaculada
    Linares Garcia, Mariano
    Diago, Moises
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2024, 116 (01) : 43 - 43
  • [7] Feasibility and safety of therapy with ibrutinib after antiviral control of hepatitis B virus (HBV) reactivation in chronic lymphocytic leukemia patients
    Molica, Stefano
    Levato, Luciano
    Mirabelli, Rosanna
    Tedeschi, Alessanda
    Lentini, Mirella
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (11) : 2734 - 2736
  • [8] EXPERIENCE OF IBRUTINIB THERAPY IN THE TREATMENT OF PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Kurkina, N. V.
    Repina, E. A.
    Mashnina, N. N.
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2017, 62 (01): : 55 - 56
  • [9] Hepatitis E virus infection and ribavirin treatment in patients with chronic lymphocytic leukemia receiving ibrutinib
    Protin, C.
    Abravanel, F.
    Laurent, G.
    Tavitian, S.
    Oberic, L.
    Izopet, J.
    Martin-Blondel, G.
    Ysebaert, L.
    Alric, L.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S250 - S250
  • [10] Ibrutinib for the treatment of chronic lymphocytic leukemia
    Deodato, Marina
    Frustaci, Anna Maria
    Zamprogna, Giulia
    Cairoli, Roberto
    Montillo, Marco
    Tedeschi, Alessandra
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (05) : 273 - 284
12345